4,5,6,7-Tetrahydro-pyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester, 95.0%, 500mg

(2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-phenylpyrrolidine-2-carboxylic acid, 95%, 250mg

Ethyl 2-(2-oxocyclopentyl)acetate, 95.0%, 25g

4-(Hydroxymethyl)cyclohexanone, 97.0%, 25g

4,6-Dibromoindoline-2,3-dione, 98%, 250mg

2-Morpholin-4-yl-pyrimidin-4-ol, 95.0%, 5g

1-Octen-3-yl Acetate>98.0%(GC)25mL

Ammonium heptamolybdate tetrahydrate, min. 99%, pa, 50 g, plastic packaging.

N-(2-(2-Methoxy-6H-dipyrido[2,3-a:3',2'-e]pyrrolizin-11-yl)ethyl)furan-2-carboxamide, 98.0%, 10mg

(2S,4S)-4-(Benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 98%, 250mg

4-Hydroxyatomoxetine, 98%, 5mg

7-BROMO-3-NITRO-4-QUINOLINOL, 95.0%, 5g

4-Formyl-3-(trifluoromethyl)benzonitrile, 98%, 1g